SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : son of T/FIF
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: biowa who wrote (201)9/30/1999 10:22:00 AM
From: LLCF  Read Replies (2) of 673
 
<And if I read them right, two (2) TWO are biotechs. >

And ENZN [one of the 2] is considered a lock to pick up royalties on SGP's next generation HEPC drug shortly.

I see AMZN the other day offering to let 'boutique' venders set up 'shop' on their web site etc. in return for % sales... stock goes up 25% or billions in mkt cap. on the news. Totally new, untested business plan. Neurocrine announces expanded P2 trials on promising candidate in a huge indication and it rallies 1/4 ... adds about $5 mill dollars to its market cap.

DAK
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News